David Bourdon - 08 Mar 2024 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Financial Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
08 Mar 2024
Net transactions value
-$407,664
Form type
4
Filing time
12 Mar 2024, 21:43:58 UTC
Previous filing
08 Mar 2023
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +104,022 +39% $0.000000 368,038 08 Mar 2024 Direct F1
transaction LFST Common Stock Award $0 +124,644 +34% $0.000000 492,682 08 Mar 2024 Direct F2
transaction LFST Common Stock Sale $407,664 -58,826 -12% $6.93 433,856 11 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 104,022 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024.
F3 Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.